Synaptic plasticity in the pathophysiology and treatment of bipolar disorder

Current Topics in Behavioral Neurosciences

Volumn 5, Issue 1, 2011, Pages 167-185

  Du, Jing ^a   Machado Vieira, Rodrigo ^a   Khairova, Rushaniya ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

BDNF; Bipolar disorder; Cytokine; Mood stabilizer; Stress; Synaptic plasticity

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; INTERLEUKIN 1; INTERLEUKIN 6; LITHIUM; NORADRENALIN; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA; VALPROIC ACID; ANTIDEPRESSANT AGENT;

ARTICLE; BIPOLAR DISORDER; CHRONIC STRESS; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DRUG MECHANISM; DRUG TARGETING; HUMAN; MOOD DISORDER; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROIMAGING; NONHUMAN; NORADRENERGIC SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; SEROTONINERGIC SYSTEM; ANIMAL; DISEASE MODEL; HIPPOCAMPUS; METABOLISM; PATHOLOGY; SYNAPSE;

ANIMALS; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; NEURONAL PLASTICITY; SYNAPSES;

EID: 84870572807     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2010_65     Document Type: Article

References (148)

1. Abe K, Fujimoto T, Akaishi T, Misawa M (2009) Stimulation of basolateral amygdaloid serotonin 5-HT(2C) receptors promotes the induction of long-term potentiation in the dentate gyrus of anesthetized rats. Neurosci Lett 451:65-68
2. Adler CM, Holland SK, Schmithorst V, Tuchfarber MJ, Strakowski SM (2004) Changes in neuronal activation in patients with bipolar disorder during performance of a working memory task. Bipolar Disord 6:540-549
3. Altshuler LL, Curran JG, Hauser P, Mintz J, Denicoff K, Post R (1995) T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis. Am J Psychiatry 152:1139-1144
4. Alzoubi KH, Aleisa AM, Alkadhi KA (2005) Impairment of long-term potentiation in the CA1, but not dentate gyrus, of the hippocampus in Obese Zucker rats: role of calcineurin and phosphorylated CaMKII. J Mol Neurosci 27:337-346
5. Avital A, Goshen I, Kamsler A, Segal M, Iverfeldt K, Richter-Levin G, Yirmiya R (2003) Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus 13:826-834
6. Balschun D, Wetzel W, Del Rey A, Pitossi F, Schneider H, Zuschratter W, Besedovsky HO (2004) Interleukin-6: a cytokine to forget. FASEB J 18:1788-1790
7. Barrientos RM, Higgins EA, Sprunger DB, Watkins LR, Rudy JW, Maier SF (2002) Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus. Behav Brain Res 134:291-298
8. Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, Beattie MS, Malenka RC (2002) Control of synaptic strength by glial TNFalpha. Science 295:2282-2285
9. Bellinger FP, Madamba S, Siggins GR (1993) Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res 628:227-234
10. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351-354
11. Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Ashworth F, Sule A, Matthews PM, Cowen PJ (2007) Reduction in occipital cortex gamma-aminobutyric acid concentrations in medicationfree recovered unipolar depressed and bipolar subjects. Biol Psychiatry 61:806-812
12. Blundon JA, Zakharenko SS (2008) Dissecting the components of long-term potentiation. Neuroscientist 14:598-608
13. Brambilla P, Harenski K, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC (2001) MRI study of posterior fossa structures and brain ventricles in bipolar patients. J Psychiatr Res 35:313-322
14. Brambilla P, Glahn DC, Balestrieri M, Soares JC (2005) Magnetic resonance findings in bipolar disorder. Psychiatr Clin North Am 28:443-467
15. Bramham CR (2007) Control of synaptic consolidation in the dentate gyrus: mechanisms, functions, and therapeutic implications. Prog Brain Res 163:453-471
16. Bramham CR (2008) Local protein synthesis, actin dynamics, and LTP consolidation. Curr Opin Neurobiol 18:524-531
17. Bramham CR, Srebro B (1989) Synaptic plasticity in the hippocampus is modulated by behavioral state. Brain Res 493:74-86
18. Bramham CR, Bacher-Svendsen K, Sarvey JM (1997) LTP in the lateral perforant path is betaadrenergic receptor-dependent. Neuroreport 8:719-724
19. Bredt DS, Nicoll RA (2003) AMPA receptor trafficking at excitatory synapses. Neuron 40:361-379
20. Butler MP, O'Connor JJ, Moynagh PN (2004) Dissection of tumor-necrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early-but not late-phase LTP. Neuroscience 124:319-326
21. Cahill AL, Perlman RL (1994) Tetraethylammonium selectively stimulates secretion from noradrenergic bovine chromaffin cells. J Auton Pharmacol 14:177-185
22. Campioni MR, Xu M, McGehee DS (2009) Stress-induced changes in nucleus accumbens glutamate synaptic plasticity. J Neurophysiol 101:3192-3198
23. Carlezon WA Jr, Nestler EJ (2002) Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? Trends Neurosci 25:610-615
24. Carrasco GA, Van de Kar LD (2003) Neuroendocrine pharmacology of stress. Eur J Pharmacol 463:235-272
25. Citri A, Malenka RC (2008) Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology 33:18-41
26. Conboy L, Sandi C (2010) Stress at learning facilitates memory formation by regulating AMPA receptor trafficking through a glucocorticoid action. Neuropsychopharmacology 35:674-685
27. Cumiskey D, Butler MP, Moynagh PN, O'Connor JJ (2007) Evidence for a role for the group I metabotropic glutamate receptor in the inhibitory effect of tumor necrosis factor-alpha on longterm potentiation. Brain Res 1136:13-19
28. Cunningham AJ, Murray CA, O'Neill LA, Lynch MA, O'Connor JJ (1996) Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 203:17-20
29. Curran B, O'Connor JJ (2001) The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro. Neuroscience 108:83-90
30. Daban C, Vieta E, Mackin P, Young AH (2005) Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr Clin North Am 28:469-480
31. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF (2004) Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 61:450-458
32. Dalia A, Uretsky NJ, Wallace LJ (1996) Induction of locomotor activity by the glutamate antagonist DNQX injected into the ventral tegmental area. Brain Res 728:209-214
33. Davis S, Laroche S (1998) A molecular biological approach to synaptic plasticity and learning. C R Acad Sci III 321:97-107
34. Dixon JF, Hokin LE (1998) Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proc Natl Acad Sci USA 95:8363-8368
35. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME (1997) Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386:824-827
36. Du J, Gray NA, Falke C, Yuan P, Szabo S, Manji HK (2003) Structurally dissimilar antimanic agents modulate synaptic plasticity by regulating AMPA glutamate receptor subunit GluR1 synaptic expression. Ann N Y Acad Sci 1003:378-380
37. Du J, Gray NA, Falke CA, Chen W, Yuan P, Szabo ST, Einat H, Manji HK (2004a) Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression. J Neurosci 24:6578-6589
38. Du J, Quiroz J, Yuan P, Zarate C, Manji HK (2004b) Bipolar disorder: involvement of signaling cascades and AMPA receptor trafficking at synapses. Neuron Glia Biol 1:231-243
39. Du J, Suzuki K, Wei Y, Wang Y, Blumenthal R, Chen Z, Falke C, Zarate CA Jr, Manji HK (2007) The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders. Neuropsychopharmacology 32:793-802
40. Du J, Creson TK, Wu LJ, Ren M, Gray NA, Falke C, Wei Y, Wang Y, Blumenthal R, Machado-Vieira R, Yuan P, Chen G, Zhuo M, Manji HK (2008) The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior. J Neurosci 28:68-79
41. Duman RS (2004) Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 5:11-25
42. Edagawa Y, Saito H, Abe K (1999) Stimulation of the 5-HT1A receptor selectively suppresses NMDA receptor-mediated synaptic excitation in the rat visual cortex. Brain Res 827:225-228
43. Edagawa Y, Saito H, Abe K (2000) The serotonin 5-HT2 receptor-phospholipase C system inhibits the induction of long-term potentiation in the rat visual cortex. Eur J Neurosci 12:1391-1396
44. Ferry B, McGaugh JL (2000) Role of amygdala norepinephrine in mediating stress hormone regulation of memory storage. Acta Pharmacol Sin 21:481-493
45. Figurov A, Pozzo-Miller LD, Olafsson P, Wang T, Lu B (1996) Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 381:706-709
46. Frey BN, Andreazza AC, Cereser KM, Martins MR, Valvassori SS, Reus GZ, Quevedo J, Kapczinski F (2006) Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci 79:281-286
47. Frey BN, Andreazza AC, Nery FG, Martins MR, Quevedo J, Soares JC, Kapczinski F (2007) The role of hippocampus in the pathophysiology of bipolar disorder. Behav Pharmacol 18:419-430
48. Gelinas JN, Nguyen PV (2005) Beta-adrenergic receptor activation facilitates induction of a protein synthesis-dependent late phase of long-term potentiation. J Neurosci 25:3294-3303
49. Gelinas JN, Banko JL, Peters MM, Klann E, Weeber EJ, Nguyen PV (2008) Activation of exchange protein activated by cyclic-AMP enhances long-lasting synaptic potentiation in the hippocampus. Learn Mem 15:403-411
50. Gibertini M, Newton C, Friedman H, Klein TW (1995) Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta. Brain Behav Immun 9:113-128
51. Golan H, Levav T, Mendelsohn A, Huleihel M (2004) Involvement of tumor necrosis factor alpha in hippocampal development and function. Cereb Cortex 14:97-105
52. Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T, Yirmiya R (2008) Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 13:717-728
53. Gould TD, Einat H, Bhat R, Manji HK (2004) AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int J Neuropsychopharmacol 7:387-390
54. Gould TD, O'Donnell KC, Dow ER, Du J, Chen G, Manji HK (2008) Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test. Neuropharmacology 54:577-587
55. Greengard P, Allen PB, Nairn AC (1999) Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23:435-447
56. Gurden H, Takita M, Jay TM (2000) Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo. J Neurosci 20:106
57. Harley CW (2004) Norepinephrine and dopamine as learning signals. Neural Plast 11:191-204
58. Hashimoto K, Shimizu E, Iyo M (2004) Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 45:104-114
59. Hirayasu Y, Shenton ME, Salisbury DF, Kwon JS, Wible CG, Fischer IA, Yurgelun-Todd D, Zarate C, Kikinis R, Jolesz FA, McCarley RW (1999) Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 156:1091-1093
60. Holderbach R, Clark K, Moreau JL, Bischofberger J, Normann C (2007) Enhanced long-term synaptic depression in an animal model of depression. Biol Psychiatry 62:92-100
61. Hu H, Real E, Takamiya K, KangMG, Ledoux J, Huganir RL, Malinow R (2007) Emotion enhances learning via norepinephrine regulation of AMPA-receptor trafficking. Cell 131:160-173
62. Hu X, Viesselmann C, Nam S, Merriam E, Dent EW (2008) Activity-dependent dynamic microtubule invasion of dendritic spines. J Neurosci 28:13094-13105
63. Inaba M, Maruyama T, Yoshimura Y, Hosoi H, Komatsu Y (2009) Facilitation of low-frequency stimulation-induced long-term potentiation by endogenous noradrenaline and serotonin in developing rat visual cortex. Neurosci Res 64:191-198
64. Jankowsky JL, Derrick BE, Patterson PH (2000) Cytokine responses to LTP induction in the rat hippocampus: a comparison of in vitro and in vivo techniques. Learn Mem 7:400-412
65. Kandel DB, Huang FY, Davies M (2001) Comorbidity between patterns of substance use dependence and psychiatric syndromes. Drug Alcohol Depend 64:233-241
66. Kapus GL, Gacsalyi I, Vegh M, Kompagne H, Hegedus E, Leveleki C, Harsing LG, Barkoczy J, Bilkei-Gorzo A, Levay G (2008) Antagonism of AMPA receptors produces anxiolytic-like behavior in rodents: effects of GYKI 52466 and its novel analogues. Psychopharmacology (Berl) 198:231-241
67. Kasper S, McEwen BS (2008) Neurobiological and clinical effects of the antidepressant tianeptine. CNS Drugs 22:15-26
68. Katsuki H, Izumi Y, Zorumski CF (1997) Noradrenergic regulation of synaptic plasticity in the hippocampal CA1 region. J Neurophysiol 77:3013-3020
69. Kemp A, Manahan-Vaughan D (2004) Hippocampal long-term depression and long-term potentiation encode different aspects of novelty acquisition. Proc Natl Acad Sci USA 101:8192-8197
70. Kendell SF, Krystal JH, Sanacora G (2005) GABA and glutamate systems as therapeutic targets in depression and mood disorders. Expert Opin Ther Targets 9:153-168
71. Kessels HW, Malinow R (2009) Synaptic AMPA receptor plasticity and behavior. Neuron 61:340-350
72. Kolomiets B, Marzo A, Caboche J, Vanhoutte P, Otani S (2009) Background dopamine concentration dependently facilitates long-term potentiation in rat prefrontal cortex through postsynaptic activation of extracellular signal-regulated kinases. Cereb Cortex 19:2708-2718
73. Konarski JZ, McIntyre RS, Kennedy SH, Rafi-Tari S, Soczynska JK, Ketter TA (2008) Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord 10:1-37
74. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T (1995) Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92:8856-8860
75. Kuipers SD, Bramham CR (2006) Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Curr Opin Drug Discov Devel 9:580-586
76. Kulla A, Manahan-Vaughan D (2002) Modulation by serotonin 5-HT(4) receptors of long-term potentiation and depotentiation in the dentate gyrus of freely moving rats. Cereb Cortex 12:150-162
77. Laakmann G (1988) Psychopharmaco-endocrinology and depression research. Monogr Gesamtgeb Psychiatr Psychiatry Ser 46:1-220
78. Lai AY, Swayze RD, El-Husseini A, Song C (2006) Interleukin-1 beta modulates AMPA receptor expression and phosphorylation in hippocampal neurons. J Neuroimmunol 175:97-106
79. Layer RT, Uretsky NJ, Wallace LJ (1993) Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference. Brain Res 617:267-273
80. Lee HK (2006) Synaptic plasticity and phosphorylation. Pharmacol Ther 112:810-832
81. Levkovitz Y, Segal M (1997) Serotonin 5-HT1A receptors modulate hippocampal reactivity to afferent stimulation. J Neurosci 17:5591-5598
82. Li AJ, Katafuchi T, Oda S, Hori T, Oomura Y (1997a) Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res 748:30-38
83. Li Y, Vartanian AJ, White FJ, Xue CJ, Wolf ME (1997b) Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine. Psychopharmacology (Berl) 134:266-276
84. Li S, Cullen WK, Anwyl R, Rowan MJ (2003) Dopamine-dependent facilitation of LTP induction in hippocampal CA1 by exposure to spatial novelty. Nat Neurosci 6:526-531
85. Lisman JE, Grace AA (2005) The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 46:703-713
86. Lu Y, Christian K, Lu B (2008) BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory? Neurobiol Learn Mem 89:312-323
87. Lynch G, Rex CS, Gall CM (2007) LTP consolidation: substrates, explanatory power, and functional significance. Neuropharmacology 52:12-23
88. Lyoo IK, Kim MJ, Stoll AL, Demopulos CM, Parow AM, Dager SR, Friedman SD, Dunner DL, Renshaw PF (2004) Frontal lobe gray matter density decreases in bipolar I disorder. Biol Psychiatry 55:648-651
89. Machacek DW, Garraway SM, Shay BL, Hochman S (2001) Serotonin 5-HT(2) receptor activation induces a long-lasting amplification of spinal reflex actions in the rat. J Physiol 537:201-207
90. Maggio N, Segal M (2009) Differential corticosteroid modulation of inhibitory synaptic currents in the dorsal and ventral hippocampus. J Neurosci 29:2857-2866
91. Maier SF, Watkins LR (1995) Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res 695:279-282
92. Malenka RC (2003a) Synaptic plasticity and AMPA receptor trafficking. Ann N Y Acad Sci 1003:1-11
93. Malenka RC (2003b) The long-term potential of LTP. Nat Rev Neurosci 4:923-926
94. Manji HK, McNamara R, Chen G, Lenox RH (1999) Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness. Aust N Z J Psychiatry 33(Suppl):S65-S83
95. Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff K, AG N, Zarate CA Jr, Charney DS (2003) Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry 53:707-742
96. Marshall RD, Garakani A (2002) Psychobiology of the acute stress response and its relationship to the psychobiology of post-traumatic stress disorder. Psychiatr Clin North Am 25:385-395
97. Martin S, Henley JM, Holman D, Zhou M, Wiegert O, van Spronsen M, Joels M, Hoogenraad CC, Krugers HJ (2009) Corticosterone alters AMPAR mobility and facilitates bidirectional synaptic plasticity. PLoS One 4:e4714
98. Massaro CM, Pielage J, Davis GW (2009) Molecular mechanisms that enhance synapse stability despite persistent disruption of the spectrin/ankyrin/microtubule cytoskeleton. J Cell Biol 187:101-117
99. Massicotte G, Bernard J, Ohayon M (1993) Chronic effects of trimipramine, an antidepressant, on hippocampal synaptic plasticity. Behav Neural Biol 59:100-106
100. Matsuda Y, Marzo A, Otani S (2006) The presence of background dopamine signal converts longterm synaptic depression to potentiation in rat prefrontal cortex. J Neurosci 26:4803-4810
101. Matsumoto M, Tachibana K, Togashi H, Tahara K, Kojima T, Yamaguchi T, Yoshioka M (2005) Chronic treatment with milnacipran reverses the impairment of synaptic plasticity induced by conditioned fear stress. Psychopharmacology (Berl) 179:606-612
102. McAfoose J, Baune BT (2009) Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 33:355-366
103. Mead AN, Stephens DN (1999) CNQX but not NBQX prevents expression of amphetamineinduced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors. J Pharmacol Exp Ther 290:9-15
104. Murray CA, Lynch MA (1998) Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age-and stress-induced impairments in long-term potentiation. J Neurosci 18:2974-2981
105. Nonaka S, Hough CJ, Chuang DM (1998) Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptormediated calcium influx. Proc Natl Acad Sci USA 95:2642-2647
106. Normann C, Clark K (2005) Selective modulation of Ca(2+) influx pathways by 5-HT regulates synaptic long-term plasticity in the hippocampus. Brain Res 1037:187-193
107. Nugent AC, Milham MP, Bain EE, Mah L, Cannon DM, Marrett S, Zarate CA, Pine DS, Price JL, Drevets WC (2006) Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry. Neuroimage 30:485-497
108. Oitzl MS, van Oers H, Schobitz B, de Kloet ER (1993) Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning. Brain Res 613:160-163
109. Patterson SL, Abel T, Deuel TA, Martin KC, Rose JC, Kandel ER (1996) Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16:1137-1145
110. Pittenger C, Duman RS (2008) Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33:88-109
111. Popoli M, Gennarelli M, Racagni G (2002) Modulation of synaptic plasticity by stress and antidepressants. Bipolar Disord 4:166-182
112. Pugh CR, Nguyen KT, Gonyea JL, Fleshner M, Wakins LR, Maier SF, Rudy JW (1999) Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation. Behav Brain Res 106:109-118
113. Pugh CR, Johnson JD, Martin D, Rudy JW, Maier SF, Watkins LR (2000) Human immunodeficiency virus-1 coat protein gp120 impairs contextual fear conditioning: a potential role in AIDS related learning and memory impairments. Brain Res 861:8-15
114. Ross FM, Allan SM, Rothwell NJ, Verkhratsky A (2003) A dual role for interleukin-1 in LTP in mouse hippocampal slices. J Neuroimmunol 144:61-67
115. Ryan BK, Anwyl R, Rowan MJ (2008) 5-HT2 receptor-mediated reversal of the inhibition of hippocampal long-term potentiation by acute inescapable stress. Neuropharmacology 55:175-182
116. Salvadore G, Drevets WC, Henter ID, Zarate CA, Manji HK (2008) Early intervention in bipolar disorder, Part I: Clinical and imaging findings. Early Interv Psychiatry 2:122-135
117. Sanberg CD, Jones FL, Do VH, Dieguez D Jr, Derrick BE (2006) 5-HT1a receptor antagonists block perforant path-dentate LTP induced in novel, but not familiar, environments. Learn Mem 13:52-62
118. Sandi C, Pinelo-Nava MT (2007) Stress and memory: behavioral effects and neurobiological mechanisms. Neural Plast 2007:78970
119. Sarvey JM, Burgard EC, Decker G (1989) Long-term potentiation: studies in the hippocampal slice. J Neurosci Methods 28:109-124
120. Savitz J, Drevets WC (2009) Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev 33:699-771
121. Setiawan E, Jackson MF, MacDonald JF, Matthews SG (2007) Effects of repeated prenatal glucocorticoid exposure on long-term potentiation in the juvenile guinea-pig hippocampus. J Physiol 581:1033-1042
122. Sharma V, Menon R, Carr TJ, Densmore M, Mazmanian D, Williamson PC (2003) An MRI study of subgenual prefrontal cortex in patients with familial and non-familial bipolar I disorder. J Affect Disord 77:167-171
123. Sheline YI (2000) 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biol Psychiatry 48:791-800
124. Shepherd JD, Huganir RL (2007) The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol 23:613-643
125. ShirayamaY, ChenAC, Nakagawa S, Russell DS, Duman RS (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22:3251-3261
126. Sonino N, Fava GA (2001) Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment. CNS Drugs 15:361-373
127. Stanton PK, Sarvey JM (1985a) Blockade of norepinephrine-induced long-lasting potentiation in the hippocampal dentate gyrus by an inhibitor of protein synthesis. Brain Res 361:276-283
128. Stanton PK, Sarvey JM (1985b) Depletion of norepinephrine, but not serotonin, reduces long-term potentiation in the dentate gyrus of rat hippocampal slices. J Neurosci 5:2169-2176
129. Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-alpha. Nature 440:1054-1059
130. Stewart CA, Reid IC (2000) Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity. Psychopharmacology (Berl) 148:217-223
131. Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J, Shear P, Adler CM (2002) Ventricular and periventricular structural volumes in first-versus multiple-episode bipolar disorder. Am J Psychiatry 159:1841-1847
132. Straube T, Korz V, Balschun D, Frey JU (2003) Requirement of beta-adrenergic receptor activation and protein synthesis for LTP-reinforcement by novelty in rat dentate gyrus. J Physiol 552:953-960
133. Sun X, Zhao Y, Wolf ME (2005) Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons. J Neurosci 25:7342-7351
134. Sun X, Milovanovic M, Zhao Y, Wolf ME (2008) Acute and chronic dopamine receptor stimulation modulates AMPA receptor trafficking in nucleus accumbens neurons cocultured with prefrontal cortex neurons. J Neurosci 28:4216-4230
135. Svenningsson P, Bateup H, Qi H, Takamiya K, Huganir RL, Spedding M, Roth BL, McEwen BS, Greengard P (2007) Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine. Eur J Neurosci 26:3509-3517
136. Swanson-Park JL, Coussens CM, Mason-Parker SE, Raymond CR, Hargreaves EL, Dragunow M, Cohen AS, Abraham WC (1999) A double dissociation within the hippocampus of dopamine D1/D5 receptor and beta-adrenergic receptor contributions to the persistence of long-term potentiation. Neuroscience 92:485-497
137. Szabo ST, Machado-Vieira R, Yuan P, Wang Y, Wei Y, Falke C, Cirelli C, Tononi G, Manji HK, Du J (2009) Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology 56:47-55
138. Tancredi V, D'Arcangelo G, Grassi F, Tarroni P, Palmieri G, Santoni A, Eusebi F (1992) Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci Lett 146:176-178
139. Tancredi V, D'Antuono M, Cafe C, Giovedi S, Bue MC, D'Arcangelo G, Onofri F, Benfenati F (2000) The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK. J Neurochem75:634-643
140. Tzschentke TM, Schmidt WJ (1997) Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization. Behav Brain Res 84:99-107
141. Venkova K, Foreman RD, Greenwood-Van Meerveld B (2009) Mineralocorticoid and glucocorticoid receptors in the amygdala regulate distinct responses to colorectal distension. Neuropharmacology 56:514-521
142. Wang JW, David DJ, Monckton JE, Battaglia F, Hen R (2008) Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J Neurosci 28:1374-1384
143. Winson J (1980) Influence of raphe nuclei on neuronal transmission from perforant pathway through dentate gyrus. J Neurophysiol 44:937-950
144. Wolf ME, Sun X, Mangiavacchi S, Chao SZ (2004) Psychomotor stimulants and neuronal plasticity. Neuropharmacology 47(Suppl 1):61-79
145. Yang CH, Huang CC, Hsu KS (2004) Behavioral stress modifies hippocampal synaptic plasticity through corticosterone-induced sustained extracellular signal-regulated kinase/mitogen-activated protein kinase activation. J Neurosci 24:11029-11034
146. Yu H, Wang Y, Pattwell S, Jing D, Liu T, Zhang Y, Bath KG, Lee FS, Chen ZY (2009) Variant BDNF Val66Met polymorphism affects extinction of conditioned aversive memory. J Neurosci 29:4056-4064
147. Yuen EY, Liu W, Karatsoreos IN, Feng J, McEwen BS, Yan Z (2009) Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory. Proc Natl Acad Sci USA 106:14075-14079
148. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856-864